‌

US Patent 10336780 Dioxolane analogues of uridine for the treatment of cancer

Patent 10336780 was granted and assigned to Medivir on July, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Medivir

Current Assignee

Medivir

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

103367800

Patent Inventor Names

Bjorn Klasson0

Anders Eneroth0

Richard Bethell0

Fredrik Oberg0

Date of Patent

July 2, 2019

Patent Application Number

162080830

Date Filed

December 3, 2018

Patent Citations

‌

US Patent 10144750 Dioxolane analogues of cytidine for the treatment of cancer

Patent Citations Received

‌

US Patent 11447511 Dioxolane analogues of uridine for the treatment of cancer

‌

US Patent 10654877 Dioxolane analogues of uridine for the treatment of cancer

‌

US Patent 10822360 Dioxolane analogues of uridine for the treatment of cancer

Patent Primary Examiner

‌

Deepak R Rao

Patent abstract

The invention provides compounds of the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10336780 Dioxolane analogues of uridine for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API